| Effect of Different Probiotic Preparations on Anti-Helicobacter PyloriTherapy-Related Side Effects: A Parallel Group, Triple Blind, Placebo-Controlled Study F Cremonini, S Di Caro, M Covino, A Armuzzi, M Gabrielli, L Santarelli, ... Official journal of the American College of Gastroenterology| ACG 97 (11 …, 2002 | 536 | 2002 |
| The role of intestinal microbiota and the immune system. F Purchiaroni, A Tortora, M Gabrielli, F Bertucci, G Gigante, G Ianiro, ... European Review for Medical & Pharmacological Sciences 17 (3), 2013 | 417 | 2013 |
| The role of small intestinal bacterial overgrowth in Parkinson's disease A Fasano, F Bove, M Gabrielli, M Petracca, MA Zocco, E Ragazzoni, ... Movement Disorders 28 (9), 1241-1249, 2013 | 355 | 2013 |
| Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth G Nucera, M Gabrielli, A Lupascu, EC Lauritano, A Santoliquido, ... Alimentary pharmacology & therapeutics 21 (11), 1391-1395, 2005 | 273 | 2005 |
| Small intestinal bacterial overgrowth: diagnosis and treatment A Gasbarrini, EC Lauritano, M Gabrielli, E Scarpellini, A Lupascu, V Ojetti, ... Digestive diseases 25 (3), 237-240, 2007 | 255 | 2007 |
| Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome A Lupascu, M Gabrielli, EC Lauritano, E Scarpellini, A Santoliquido, ... Alimentary pharmacology & therapeutics 22 (11‐12), 1157-1160, 2005 | 250 | 2005 |
| Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study M Gabrielli, F Cremonini, G Fiore, G Addolorato, C Padalino, M Candelli, ... The American journal of gastroenterology 98 (3), 625-629, 2003 | 198 | 2003 |
| Small intestinal bacterial overgrowth recurrence after antibiotic therapy EC Lauritano, M Gabrielli, E Scarpellini, A Lupascu, M Novi, S Sottili, ... Official journal of the American College of Gastroenterology| ACG 103 (8 …, 2008 | 189 | 2008 |
| Association between hypothyroidism and small intestinal bacterial overgrowth EC Lauritano, AL Bilotta, M Gabrielli, E Scarpellini, A Lupascu, ... The Journal of Clinical Endocrinology & Metabolism 92 (11), 4180-4184, 2007 | 181 | 2007 |
| Prevalence of small intestinal bacterial overgrowth in Parkinson's disease M Gabrielli, P Bonazzi, E Scarpellini, E Bendia, EC Lauritano, A Fasano, ... Movement disorders 26 (5), 889-892, 2011 | 180 | 2011 |
| High dosage rifaximin for the treatment of small intestinal bacterial overgrowth E Scarpellini, M Gabrielli, CE Lauritano, A Lupascu, G Merra, ... Alimentary pharmacology & therapeutics 25 (7), 781-786, 2007 | 178 | 2007 |
| Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth EC Lauritano, M Gabrielli, A Lupascu, A Santoliquido, G Nucera, ... Alimentary pharmacology & therapeutics 22 (1), 31-35, 2005 | 170 | 2005 |
| Beneficial effects of Helicobacter pylori eradication on migraine. A Gasbarrini, A De Luca, G Fiore, M Gambrielli, F Franceschi, V Ojetti, ... Hepato-gastroenterology 45 (21), 765-770, 1998 | 169 | 1998 |
| High prevalence of celiac disease in patients with lactose intolerance V Ojetti, G Nucera, A Migneco, M Gabrielli, C Lauritano, S Danese, ... Digestion 71 (2), 106-110, 2005 | 166 | 2005 |
| Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? E Scarpellini, V Valenza, M Gabrielli, EC Lauritano, G Perotti, G Merra, ... Official journal of the American College of Gastroenterology| ACG 105 (2 …, 2010 | 149 | 2010 |
| Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial EC Nista, M Candelli, F Cremonini, IA Cazzato, S Di Caro, M Gabrielli, ... Alimentary pharmacology & therapeutics 18 (6), 627-633, 2003 | 145 | 2003 |
| Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. EC Lauritano, M Gabrielli, E Scarpellini, V Ojetti, D Roccarina, A Villita, ... European Review for Medical & Pharmacological Sciences 13 (2), 2009 | 132 | 2009 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 122 | 2020 |
| The role of methane in intestinal diseases D Roccarina, EC Lauritano, M Gabrielli, F Franceschi, V Ojetti, ... Official journal of the American College of Gastroenterology| ACG 105 (6 …, 2010 | 119 | 2010 |
| The effect of oral supplementation with V Ojetti, G Gigante, M Gabrielli, ME Ainora, A Mannocci, EC Lauritano, ... European review for medical and pharmacological sciences 14, 163-70, 2010 | 112 | 2010 |
